IBDEI2VX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48446,1,4,0)
 ;;=4^Z89.611
 ;;^UTILITY(U,$J,358.3,48446,2)
 ;;=^5063572
 ;;^UTILITY(U,$J,358.3,48447,0)
 ;;=Z89.612^^216^2406^7
 ;;^UTILITY(U,$J,358.3,48447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48447,1,3,0)
 ;;=3^Acquired absence of left leg above knee
 ;;^UTILITY(U,$J,358.3,48447,1,4,0)
 ;;=4^Z89.612
 ;;^UTILITY(U,$J,358.3,48447,2)
 ;;=^5063573
 ;;^UTILITY(U,$J,358.3,48448,0)
 ;;=Z89.622^^216^2406^6
 ;;^UTILITY(U,$J,358.3,48448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48448,1,3,0)
 ;;=3^Acquired absence of left hip joint
 ;;^UTILITY(U,$J,358.3,48448,1,4,0)
 ;;=4^Z89.622
 ;;^UTILITY(U,$J,358.3,48448,2)
 ;;=^5063576
 ;;^UTILITY(U,$J,358.3,48449,0)
 ;;=Z89.621^^216^2406^20
 ;;^UTILITY(U,$J,358.3,48449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48449,1,3,0)
 ;;=3^Acquired absence of right hip joint
 ;;^UTILITY(U,$J,358.3,48449,1,4,0)
 ;;=4^Z89.621
 ;;^UTILITY(U,$J,358.3,48449,2)
 ;;=^5063575
 ;;^UTILITY(U,$J,358.3,48450,0)
 ;;=R47.01^^216^2407^1
 ;;^UTILITY(U,$J,358.3,48450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48450,1,3,0)
 ;;=3^Aphasia
 ;;^UTILITY(U,$J,358.3,48450,1,4,0)
 ;;=4^R47.01
 ;;^UTILITY(U,$J,358.3,48450,2)
 ;;=^5019488
 ;;^UTILITY(U,$J,358.3,48451,0)
 ;;=I69.320^^216^2407^2
 ;;^UTILITY(U,$J,358.3,48451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48451,1,3,0)
 ;;=3^Aphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,48451,1,4,0)
 ;;=4^I69.320
 ;;^UTILITY(U,$J,358.3,48451,2)
 ;;=^5007491
 ;;^UTILITY(U,$J,358.3,48452,0)
 ;;=I69.120^^216^2407^3
 ;;^UTILITY(U,$J,358.3,48452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48452,1,3,0)
 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,48452,1,4,0)
 ;;=4^I69.120
 ;;^UTILITY(U,$J,358.3,48452,2)
 ;;=^5007427
 ;;^UTILITY(U,$J,358.3,48453,0)
 ;;=I69.020^^216^2407^4
 ;;^UTILITY(U,$J,358.3,48453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48453,1,3,0)
 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,48453,1,4,0)
 ;;=4^I69.020
 ;;^UTILITY(U,$J,358.3,48453,2)
 ;;=^5007395
 ;;^UTILITY(U,$J,358.3,48454,0)
 ;;=I69.820^^216^2407^5
 ;;^UTILITY(U,$J,358.3,48454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48454,1,3,0)
 ;;=3^Aphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,48454,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,48454,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,48455,0)
 ;;=I69.220^^216^2407^6
 ;;^UTILITY(U,$J,358.3,48455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48455,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,48455,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,48455,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,48456,0)
 ;;=I69.290^^216^2407^11
 ;;^UTILITY(U,$J,358.3,48456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48456,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,48456,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,48456,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,48457,0)
 ;;=I69.390^^216^2407^7
 ;;^UTILITY(U,$J,358.3,48457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48457,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,48457,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,48457,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,48458,0)
 ;;=I69.190^^216^2407^8
 ;;^UTILITY(U,$J,358.3,48458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48458,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,48458,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,48458,2)
 ;;=^5007452
